Novartis raises full-year guidance on Q1 beat, drug sales

Novartis News

Novartis raises full-year guidance on Q1 beat, drug sales
Steady GainsMarket OpenPre-Market Trading Session
  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 45 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 63%

Shares of Novartis (NVS) are soaring in Tuesday's pre-market trading session — holding onto steady gains into the market open — after the Swiss...

) are soaring in Tuesday's pre-market trading session — holding onto steady gains into the market open — after the Swiss pharmaceutical giant reported better-than-expected first-quarter earnings and raised its full-year guidance. The robust financial performance was driven primarily by strong sales of the company's innovative heart failure and psoriasis treatment drugs.

The price of gold continues to hit the headlines, but this material is also making waves and should continue to climb for investors. The post Forget Gold: This Other Metal Is Sure to Soar Higher! appeared first on The Motley Fool Canada.Rivian stock hit the market at $78 per share on Nov. 9, 2021, in the largest initial public offering of the year and the seventh-largest U.S. IPO of all time, according to Statista. Find Out: 10...

Canadian AI stocks like Open Text Corp are changing the game. The post 3 Artificial Intelligence Stocks to Buy With $500 and Hold Forever appeared first on The Motley Fool Canada.Tesla has been the most valuable car company on earth for about 1,400 days. Its reign could come to an end.In this piece, we will take a look at Cathie Wood’s latest investment portfolio and her top ten stock picks. If you want to skip our coverage of Ms.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

YahooFinanceCA /  🏆 47. in CA

Steady Gains Market Open Pre-Market Trading Session Pharmaceutical Giant

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Tilray reports US$105-million loss, cuts earnings forecastTilray reports US$105-million loss, cuts earnings forecastShares of Tilray plunged more than 20 per cent on the Toronto Stock Exchange on Tuesday
Read more »

Novartis begins tender offer for MorphoSysNovartis begins tender offer for MorphoSysExplore stories from Atlantic Canada.
Read more »

Swiss pharmaceutical company Novartis to cut 680 jobs in product developmentSwiss pharmaceutical company Novartis to cut 680 jobs in product developmentAround 440 jobs will go in Switzerland and up to 240 in the United States over the next two to three years, the Basel-based company said
Read more »

Novartis Seeks Malaria Patients in New Places as Climate ShiftsNovartis Seeks Malaria Patients in New Places as Climate ShiftsMalaria season should be over in Burkina Faso and Mali. This year, that’s not the case, and health workers from drugmaker Novartis AG are still enrolling young patients into a study for a new treatment.
Read more »

Maple Leafs’ Morgan Rielly out with lower-body injury, won’t play Tuesday vs. DevilsMaple Leafs’ Morgan Rielly out with lower-body injury, won’t play Tuesday vs. DevilsRielly has 51 points in 65 games with the Maple Leafs this season.
Read more »

S&P/TSX composite ticks lower Tuesday, U.S. markets also take a dipS&P/TSX composite ticks lower Tuesday, U.S. markets also take a dipTORONTO — Canada's main stock index was down almost 30 points Tuesday, led by weakness in energy and base metals, while U.S. markets also moved into the red after drifting higher for most of the day. A late-day drop for Nvidia dragged U.S.
Read more »



Render Time: 2025-02-13 12:54:48